Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Long-term use of dutasteride can cause permanent erectile dysfunction in rats.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Dutasteride is the most effective hair loss treatment after 24 weeks, but finasteride leads to the most hair growth after 48 weeks.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Men on 5-alpha-reductase inhibitors might have worse COVID-19 outcomes.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

Hair loss drugs like finasteride may cause lasting sexual and mood side effects, and more research is needed to understand these risks.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

A topical treatment safely and effectively reduced acne by causing targeted cell death in sebaceous glands without side effects.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Tamsulosin with Serenoa repens is as effective as with 5-alpha-reductase inhibitors but causes fewer side effects.

Men using 5-alpha reductase inhibitors for prostate issues may have a slightly higher risk of blood clots.

The review found that women using hair loss drugs like finasteride and dutasteride rarely reported sexual side effects.

Finasteride reduces prostate size and symptoms with few side effects.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

Nanostructured delivery systems could potentially improve hair loss treatment by targeting drugs to hair follicles, reducing side effects and dosage, but the best size, charge, and materials for these systems need further investigation.

Older patients sticking to their prostate medication saw lasting health benefits.

Most legal cases about 5α-reductase inhibitors, drugs for hair loss and prostate issues, complain about side effects and delayed cancer diagnosis, with most lawsuits settled out of court.

Oral finasteride and dutasteride may negatively affect erectile function in rats.

The document concludes that women should not use 5-alpha-reductase inhibitors due to the risk of birth defects and limited effectiveness.

Finasteride may increase the risk of suicidality and depression, especially in younger people.

5α-reductase inhibitors may help with prostate cancer but could increase the risk of severe tumors, so careful use is advised.

Finasteride reduces some inflammation in BPH but not all.

The new compound may be a safer alternative to finasteride for prostate protection.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

5α-reductase inhibitors may increase the risk of depression and suicidal thoughts.